Phase 2 Prostate Cancer Metastatic Clinical Trials
14 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–14 of 14 trials
Recruiting
Phase 2
Castrate Resistant Prostate Cancer Enhertu Therapy
Prostate CancerProstate Cancer MetastaticCRPC
Washington D.C. Veterans Affairs Medical Center60 enrolled1 locationNCT06610825
Recruiting
Phase 2
Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)
Prostate Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM)80 enrolled1 locationNCT05457699
Recruiting
Phase 2
Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients
Prostate Cancer Metastatic Disease
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine192 enrolled1 locationNCT06832774
Recruiting
Phase 2
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Prostate CancerProstate CarcinomaProstate Neoplasm+12 more
Shehzad Basaria, M.D.60 enrolled1 locationNCT06957691
Recruiting
Phase 2
Using FAPI PET/MRI to Evaluate Prostate Cancer
Prostate CancersProstate Cancer Metastatic Disease
University of Wisconsin, Madison30 enrolled1 locationNCT06675357
Recruiting
Phase 2
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
Prostate Cancer SurgeryProstate Cancer Metastatic Disease
Clinton Bahler22 enrolled3 locationsNCT06849544
Recruiting
Phase 1Phase 2
A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
Breast Cancer MetastaticRenal Cell Carcinoma MetastaticProstate Cancer Metastatic+2 more
Kidney Cancer Research Bureau58 enrolled5 locationsNCT07292168
Recruiting
Phase 2
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
Prostate CancerProstate Cancer Metastatic
Martha Mims130 enrolled3 locationsNCT03833921
Recruiting
Phase 1Phase 2
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
Metastatic Colorectal CancerProstate Cancer MetastaticProstate Cancer Locally Advanced
Curacell Holding AB12 enrolled1 locationNCT07255664
Recruiting
Phase 1Phase 2
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Disease
Halda Therapeutics OpCo, Inc.33 enrolled11 locationsNCT06800313
Recruiting
Phase 2
Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Castration-ResistantProstate Adenocarcinoma With Neuroendocrine Differentiation
Tianjin Medical University Second Hospital28 enrolled1 locationNCT07179783
Recruiting
Phase 2
Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC
Prostate Cancer Metastatic Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School144 enrolled1 locationNCT06992232
Recruiting
Phase 2
Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
Prostate Cancer Metastatic
Fundacion Oncosur42 enrolled1 locationNCT05563558
Recruiting
Phase 1Phase 2
National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
Prostate Cancer Metastatic
Peter Busch Østergren20 enrolled1 locationNCT04086290